You are here: Industry Insights > drugmaker

News List

Insys agrees to sell notorious fentanyl spray to drugmaker promising good behavior fiercepharma
September 26, 2019
A Delaware bankruptcy judge cleared the sale of the highly addictive, under-the-tongue fentanyl spray Subsys to Wyoming-based BTcP Pharma LLC, part of the MMB Healthcare network. The deal could net Insys $20 million in royalties.
Takeda staffers accuse drugmaker of favoring Shire employees during merger fiercepharma
August 13, 2019
During a merger, one might suspect a buyer could favor its old employees over the newcomers. But that’s not what's happened at Takeda Korea as it folds in Shire, according to a labor union.
South Florida drugmaker opens sterile drug facility fiercepharma
April 25, 2019
A South Florida company working on generic sterile injectable drugs is moving toward a fully automated manufacturing facility to be ready when its candidates are.
Novartis chairman says drugmaker has no plans to offload Sandoz unit firstwordpharma
March 06, 2019
According to an interview published Monday in the Finanz und Wirtschaft newspaper, Novartis chairman Joerg Reinhardt indicated that the company does not intend to divest its Sandoz generics business, nor any parts of it.
Tesaro's deal struggles? They're actually a good omen for Clovis: analyst fiercepharma
December 20, 2018
PARP drugmaker Tesaro may have had a tough time finding a buyer in GlaxoSmithKline. But that doesn’t mean rival Clovis won’t be able to land its own, one analyst says.
FDA grants priority review to Novartis' filing seeking clearance of gene therapy for spinal muscular atrophy firstwordpharma
December 03, 2018
Novartis said Monday that the FDA granted priority review to an application seeking approval of Zolgensma (onasemnogene abeparvovec) for the treatment of spinal muscular atrophy (SMA) Type 1, with the agency setting a target data in May next year.
Sun gets dermatology portfolio, two plants in Japan with Pola Pharma deal expressbpd
November 27, 2018
Acquisition to help in building global dermatology business
Bayer, Sanofi in executive swap as French drugmaker refocuses two global business units firstwordpharma
September 14, 2018
Bayer announced Thursday that Stefan Oelrich, who currently heads Sanofi's global diabetes and cardiovascular business, will join the company to lead its pharmaceuticals division, replacing Dieter Weinand.
Drugmaker GSK to eliminate 650 US jobs financialexpress
September 07, 2018
The savings from these cuts will help fund increases in research and development and commercial support of new products, Rhyne said
FDA hits Mexican drugmaker Degasa with warning letter fiercepharma
May 02, 2018
The FDA issued a warning letter to Mexican finished-pharmaceutical manufacturer Degasa for issues including misbranding...

Previous page 1 2 Next page